Lung cancer in a young adult Fontan: what would you do?
1/5 보강
Primary pulmonary malignancies in single-ventricle patients are rare.
APA
Sefah AO, Hasselman TE, Turbendian HK (2026). Lung cancer in a young adult Fontan: what would you do?. Cardiology in the young, 1-2. https://doi.org/10.1017/S1047951125110615
MLA
Sefah AO, et al.. "Lung cancer in a young adult Fontan: what would you do?." Cardiology in the young, 2026, pp. 1-2.
PMID
41527719 ↗
Abstract 한글 요약
Primary pulmonary malignancies in single-ventricle patients are rare. Improved survival following surgical palliation has resulted in a growing Fontan population whose malignancy risk remains undefined. Standard oncologic approaches, especially for adenocarcinoma of the lung, need to be considered within the context of Fontan physiology. We present our management of primary lung adenocarcinoma in an adult with tricuspid atresia status postlateral tunnel Fontan palliation, highlighting considerations for this unique scenario.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.
- Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.
- Multi-omics analysis and experiments validate the tumor-suppressive role of mitochondrial lipid metabolism gene ACSM5 in lung adenocarcinoma and its impact on the immune microenvironment.
- Prediction of high-risk factor in early-stage lung cancer: micropapillary adenocarcinoma.
- Integrated bulk and single-cell transcriptomics with experimental validation to identify calmodulin-related prognostic genes in lung adenocarcinoma.